Diagnostic value of peptidome analyses for protease activated pathological conditions beyond cancer diagnosis
Diagnostic value of peptidome analyses for protease activated pathological conditions beyond cancer diagnosis
批准号:
19390156
负责人:
HASHIGUCHI Teruto
金额:
$12.4万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (B)
财政年份:
2007
资助国家:
日本
项目状态:
已结题
起止时间:
2007 至 2009
中文摘要
人血清含有成千上万的蛋白水解衍生的低分子量肽片段(血清肽穹)。利用血清肽球进行癌症诊断的概念已经发展起来。当蛋白酶和蛋白酶抑制剂之间的稳态平衡被破坏时,就会出现病理性血清肽丘。我们假设分析血清肽肽是否具有诊断价值,作为哪些分子被破坏的信息,以及在未知病理条件和弥散性血管内凝血(DIC)中它将采取的病理过程。我们采用基于一维凝胶电泳/基质辅助激光解吸/电离质谱(1-DE/MS)的快速定量方法,分析了1例难治性疾病POEMS(多发性神经病变、器官肿大、内分泌病变、M蛋白和皮肤变化)综合征患者3个阶段(早期、DIC前期和DIC阶段)的血清肽水平。与DIC前期相比,DIC阶段出现了大量的肽片段。此外,我们发现转甲状腺素片段(ALGISPFHEHAEVVFTANDSGPR, m/z 2,451.18)和α1-抗胰蛋白酶片段(EDPQGDAAQKTDTSHHDQDHPTFN, m/z 2,691.02)在DIC阶段与DIC前期相比显著增加。对血清肽肽的快速分析可能会导致一种诊断方法,可以预测正在进行的蛋白酶激活的病理状况,并有助于决定包括营养支持和药物治疗在内的多边策略。
英文摘要
Human serum contains thousands of proteolytically derived low-molecular-weight peptide fragments (serum peptidome). The concept of utilizing the serum peptidome for cancer diagnosis has been developed. A pathological serum peptidome appears when the homeostatic balance between proteases and protease inhibitors is disrupted. We hypothesize if analyses of the serum peptidome are of diagnostic value as information on which molecules are disrupted, and the pathological course it will take in unknown pathological conditions and disseminated intravascular coagulation (DIC). We analyzed the serum peptidome in 3 stages (early stage, pre-DIC and DIC stages) in one patient with POEMS (polyneuropathy, organomegaly, endocrinopathy, M protein and skin changes) syndrome, an intractable disease with unknown pathology, using a 1-dimensional gel electrophoresis/ matrix-assisted laser desorption/ionization-mass spectrometry (1-DE/MS)-based rapid quantitative approach. A very large number of peptide fragments appeared in the DIC stage, compared to pre-DIC. In addition, we identified fragments of transthyretin (ALGISPFHEHAEVVFTANDSGPR, m/z 2,451.18) and α1-antitrypsin (EDPQGDAAQKTDTSHHDQDHPTFN, m/z 2,691.02) that significantly increased in the DIC stage, compared to those in the pre-DIC stage. Rapid analyses of the serum peptidome may lead to a diagnostic method that can predict on-going protease activated pathological conditions and help to decide on multilateral strategies including nutritional support and drug therapy.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
DOI:
10.2147/vhrm.s8950
发表时间:
2010-03-24
期刊:
Vascular health and risk management
影响因子:
2.9
作者:
[Ohno Y, Hashiguchi T, Maenosono R, Yamashita H, Taira Y, Minowa K, Yamashita Y, Kato Y, Kawahara K, Maruyama I]
通讯作者:
Maruyama I
DOI:
10.1111/j.1464-5491.2009.02680.x
发表时间:
2009-03-01
期刊:
DIABETIC MEDICINE
影响因子:
3.5
作者:
[Deguchi, T., Hashiguchi, T., Arimura, K.]
通讯作者:
Arimura, K.
新規癌マーカーおよびそれを用いた診断
新的癌症标记物和使用它们的诊断
DOI:
--
发表时间:
2009
期刊:
影响因子:
--
作者:
[]
通讯作者:
Degradation of homeostatic molecules in the state of DIC/MOF
DIC/MOF 状态下稳态分子的降解
DOI:
--
发表时间:
2007
期刊:
影响因子:
--
作者:
[橋口照人, 李 良子, 田中憲次, 丸山征郎]
通讯作者:
丸山征郎
DIC/MOFにおける生体内蛋白分解の網羅的解析
DIC/MOF体内蛋白质降解综合分析
DOI:
--
发表时间:
2007
期刊:
影响因子:
--
作者:
[橋口照人, 川原幸一, 丸山征郎, 李良子, 田中憲次]
通讯作者:
田中憲次
共 12 条
Contribution of vascular permeability for aging erythrocyte selection in spleen
-
批准号:24659282
-
项目类别:Grant-in-Aid for Challenging Exploratory Research
-
资助金额:$2.58万
-
财政年份:2012
-
负责人:HASHIGUCHI Teruto
-
依托单位:
Immunomodulatory effects ofB cell derivedVEGF-A in mice
-
批准号:22390179
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$11.9万
-
财政年份:2010
-
负责人:HASHIGUCHI Teruto
-
依托单位:
Proteomic analysis of Crow-Fukase syndrome
-
批准号:17590888
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.24万
-
财政年份:2005
-
负责人:HASHIGUCHI Teruto
-
依托单位:
Investigation of the unknown factor over stimulating the VEGF prodution in Crow-Fukase syndrome.
-
批准号:15590901
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.24万
-
财政年份:2003
-
负责人:HASHIGUCHI Teruto
-
依托单位:
Proposal of the new concept, "Platelet VEGF"
-
批准号:13670659
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$0.77万
-
财政年份:2001
-
负责人:HASHIGUCHI Teruto
-
依托单位:
海外基金